Industry: Pharma & Healthcare
Published Date: 2024-04-12
Pages: 109 Pages
Report ld: 2920504
Request Sample
Customized Report
Insulin Preparation Market Size(US$)

CAGR 2024-2030
5.1%
Market Size,2030
USD 36,510
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
The global Insulin Preparation market is projected to grow from US$ 27090 million in 2024 to US$ 36510 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.
The Insulin Preparation market is driven by the escalating global prevalence of diabetes and the growing need for effective diabetes management solutions. Insulin, a critical hormone for regulating blood sugar levels, plays a pivotal role in treating both type 1 and type 2 diabetes. The rise in diabetes cases, particularly due to sedentary lifestyles and unhealthy dietary habits, contributes to market growth as patients and healthcare providers seek reliable and accessible insulin preparations. Moreover, advancements in insulin delivery methods, such as pens, pumps, and inhalers, align with improved treatment convenience and adherence. However, the market also faces challenges, including the complexity of insulin dosing and administration, and the need for continuous patient education. Additionally, ensuring affordability and accessibility of insulin products, particularly in low-resource settings, and addressing potential adverse effects can pose obstacles for manufacturers. To succeed, companies must focus on patient-centric solutions, technological innovations in insulin delivery, and addressing the challenges to meet the increasing demand for safe and effective insulin preparations that enhance the quality of life for individuals living with diabetes.
Report Covers:
This report presents an overview of global market for Insulin Preparation, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Insulin Preparation, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Insulin Preparation, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Insulin Preparation sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Insulin Preparation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Insulin Preparation sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Insulin Preparation in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Insulin Preparation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Preparation sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Insulin Preparation Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Preparation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Fast-acting
1.2.3 Intermediate-acting
1.2.4 Long-acting
1.3 Market by Application
1.3.1 Global Insulin Preparation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Insulin Preparation Sales Estimates and Forecasts 2019-2030
2.2 Global Insulin Preparation Revenue by Region
2.2.1 Global Insulin Preparation Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Insulin Preparation Revenue by Region (2019-2024)
2.2.3 Global Insulin Preparation Revenue by Region (2025-2030)
2.2.4 Global Insulin Preparation Revenue Market Share by Region (2019-2030)
2.3 Global Insulin Preparation Sales Estimates and Forecasts 2019-2030
2.4 Global Insulin Preparation Sales by Region
2.4.1 Global Insulin Preparation Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Insulin Preparation Sales by Region (2019-2024)
2.4.3 Global Insulin Preparation Sales by Region (2025-2030)
2.4.4 Global Insulin Preparation Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Insulin Preparation Sales by Manufacturers
3.1.1 Global Insulin Preparation Sales by Manufacturers (2019-2024)
3.1.2 Global Insulin Preparation Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Preparation in 2023
3.2 Global Insulin Preparation Revenue by Manufacturers
3.2.1 Global Insulin Preparation Revenue by Manufacturers (2019-2024)
3.2.2 Global Insulin Preparation Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Preparation Revenue in 2023
3.3 Global Key Players of Insulin Preparation, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Insulin Preparation Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Insulin Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Insulin Preparation, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Insulin Preparation, Product Offered and Application
3.8 Global Key Manufacturers of Insulin Preparation, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Preparation Sales by Type
4.1.1 Global Insulin Preparation Historical Sales by Type (2019-2024)
4.1.2 Global Insulin Preparation Forecasted Sales by Type (2025-2030)
4.1.3 Global Insulin Preparation Sales Market Share by Type (2019-2030)
4.2 Global Insulin Preparation Revenue by Type
4.2.1 Global Insulin Preparation Historical Revenue by Type (2019-2024)
4.2.2 Global Insulin Preparation Forecasted Revenue by Type (2025-2030)
4.2.3 Global Insulin Preparation Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Preparation Price by Type
4.3.1 Global Insulin Preparation Price by Type (2019-2024)
4.3.2 Global Insulin Preparation Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Insulin Preparation Sales by Application
5.1.1 Global Insulin Preparation Historical Sales by Application (2019-2024)
5.1.2 Global Insulin Preparation Forecasted Sales by Application (2025-2030)
5.1.3 Global Insulin Preparation Sales Market Share by Application (2019-2030)
5.2 Global Insulin Preparation Revenue by Application
5.2.1 Global Insulin Preparation Historical Revenue by Application (2019-2024)
5.2.2 Global Insulin Preparation Forecasted Revenue by Application (2025-2030)
5.2.3 Global Insulin Preparation Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Preparation Price by Application
5.3.1 Global Insulin Preparation Price by Application (2019-2024)
5.3.2 Global Insulin Preparation Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Insulin Preparation Market Size by Type
6.1.1 US & Canada Insulin Preparation Sales by Type (2019-2030)
6.1.2 US & Canada Insulin Preparation Revenue by Type (2019-2030)
6.2 US & Canada Insulin Preparation Market Size by Application
6.2.1 US & Canada Insulin Preparation Sales by Application (2019-2030)
6.2.2 US & Canada Insulin Preparation Revenue by Application (2019-2030)
6.3 US & Canada Insulin Preparation Market Size by Country
6.3.1 US & Canada Insulin Preparation Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Insulin Preparation Sales by Country (2019-2030)
6.3.3 US & Canada Insulin Preparation Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Insulin Preparation Market Size by Type
7.1.1 Europe Insulin Preparation Sales by Type (2019-2030)
7.1.2 Europe Insulin Preparation Revenue by Type (2019-2030)
7.2 Europe Insulin Preparation Market Size by Application
7.2.1 Europe Insulin Preparation Sales by Application (2019-2030)
7.2.2 Europe Insulin Preparation Revenue by Application (2019-2030)
7.3 Europe Insulin Preparation Market Size by Country
7.3.1 Europe Insulin Preparation Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Insulin Preparation Sales by Country (2019-2030)
7.3.3 Europe Insulin Preparation Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Insulin Preparation Market Size
8.1.1 China Insulin Preparation Sales (2019-2030)
8.1.2 China Insulin Preparation Revenue (2019-2030)
8.2 China Insulin Preparation Market Size by Application
8.2.1 China Insulin Preparation Sales by Application (2019-2030)
8.2.2 China Insulin Preparation Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Insulin Preparation Market Size by Type
9.1.1 Asia Insulin Preparation Sales by Type (2019-2030)
9.1.2 Asia Insulin Preparation Revenue by Type (2019-2030)
9.2 Asia Insulin Preparation Market Size by Application
9.2.1 Asia Insulin Preparation Sales by Application (2019-2030)
9.2.2 Asia Insulin Preparation Revenue by Application (2019-2030)
9.3 Asia Insulin Preparation Sales by Region
9.3.1 Asia Insulin Preparation Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Insulin Preparation Revenue by Region (2019-2030)
9.3.3 Asia Insulin Preparation Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Insulin Preparation Market Size by Type
10.1.1 Middle East, Africa and Latin America Insulin Preparation Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Insulin Preparation Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Insulin Preparation Market Size by Application
10.2.1 Middle East, Africa and Latin America Insulin Preparation Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Insulin Preparation Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Insulin Preparation Sales by Country
10.3.1 Middle East, Africa and Latin America Insulin Preparation Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Insulin Preparation Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Insulin Preparation Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novo Nordisk Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Information
11.2.2 Sanofi-Aventis Overview
11.2.3 Sanofi-Aventis Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Sanofi-Aventis Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi-Aventis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Eli Lilly Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Tonghua Dongbao
11.4.1 Tonghua Dongbao Company Information
11.4.2 Tonghua Dongbao Overview
11.4.3 Tonghua Dongbao Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Tonghua Dongbao Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tonghua Dongbao Recent Developments
11.5 Ganlee
11.5.1 Ganlee Company Information
11.5.2 Ganlee Overview
11.5.3 Ganlee Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Ganlee Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ganlee Recent Developments
11.6 United Laboratory
11.6.1 United Laboratory Company Information
11.6.2 United Laboratory Overview
11.6.3 United Laboratory Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 United Laboratory Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United Laboratory Recent Developments
11.7 Biocon
11.7.1 Biocon Company Information
11.7.2 Biocon Overview
11.7.3 Biocon Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Biocon Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biocon Recent Developments
11.8 Amphastar
11.8.1 Amphastar Company Information
11.8.2 Amphastar Overview
11.8.3 Amphastar Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Amphastar Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amphastar Recent Developments
11.9 Wockhardt
11.9.1 Wockhardt Company Information
11.9.2 Wockhardt Overview
11.9.3 Wockhardt Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Wockhardt Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Wockhardt Recent Developments
11.10 Julphar Diabetes
11.10.1 Julphar Diabetes Company Information
11.10.2 Julphar Diabetes Overview
11.10.3 Julphar Diabetes Insulin Preparation Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Julphar Diabetes Insulin Preparation Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Julphar Diabetes Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Preparation Industry Chain Analysis
12.2 Insulin Preparation Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Preparation Production Mode & Process
12.4 Insulin Preparation Sales and Marketing
12.4.1 Insulin Preparation Sales Channels
12.4.2 Insulin Preparation Distributors
12.5 Insulin Preparation Customers
13 Market Dynamics
13.1 Insulin Preparation Industry Trends
13.2 Insulin Preparation Market Drivers
13.3 Insulin Preparation Market Challenges
13.4 Insulin Preparation Market Restraints
14 Key Findings in The Global Insulin Preparation Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Insulin Preparation was valued at US$ 27090 million in the year 2024 and is projected to reach a revised size of US$ 38190 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-01
Pages: 86
USD 2900.00
(Single User License)
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published Date: 2024-01-12
Pages: 89
USD 2900.00
(Single User License)
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published Date: 2024-01-08
Pages: 122
USD 3950.00
(Single User License)
The global market for Insulin Preparation was valued at US$ 27090 million in the year 2024 and is projected to reach a revised size of US$ 38190 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-01
Pages: 86
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published: 2024-01-12
Pages: 89
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published: 2024-01-08
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now